0001127602-23-027226.txt : 20231113
0001127602-23-027226.hdr.sgml : 20231113
20231113161219
ACCESSION NUMBER: 0001127602-23-027226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231109
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaPlume Joseph W
CENTRAL INDEX KEY: 0001767215
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 231398825
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE STREET
CITY: WILMINGTON
STATE: MA
ZIP: 01887
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1230
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-11-09
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001767215
LaPlume Joseph W
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
EVP, Corp Strategy & Develop
0
Common Stock
2023-11-09
4
M
0
9128
144.67
A
34111
D
Common Stock
2023-11-09
4
S
0
2585
172.77
D
31526
D
Common Stock
2023-11-09
4
S
0
6543
173.76
D
24983
D
Stock Options (Right to Buy)
144.67
2023-11-09
4
M
0
9128
0
D
2020-02-22
2024-02-22
Common Stock
9128
0
D
This transaction was executed in multiple trades at prices ranging from $172.32 to $173.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $173.74 to $174.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Joseph W. LaPlume
2023-11-13